Re: SPPI
The drug may very well be "crap" per Wallstarb's def (which is obviously the ability to generate income).
The ability of SPPI to turn it into something valuable depends on several things, LEAST of which is this FDA decision.
So, this move pre-post PDUFA is ABSURDLY overblown.
I sold off half my shares minutes ago to de-risk it, and feel that I am doing little more than playing along with the HEB'ettes in holding on to any remaining shares.
I do think the odds with the FDA are good (better than Wallstarb's numbers), and that's what tempts me to gamble.
But if I any hold shares through the decision I will with 100% certainty sell ASAP on a thumbs up (even after hours if possible).
I may very well buy back in later, as I do agree with you long term. But short term there is a complete disconnect between the stock price and the company prospects.
Short term this reminds me of GTCB a few months back. A overblown run-up based on an FDA decision, then a fall back once the speculators left town.
